Publisher Correction: Refinement of an ovine-based immunoglobulin therapy against SARS-CoV-2, with comparison of whole IgG versus F(ab′)2 fragments (Scientific Reports, (2023), 13, 1, (13912), 10.1038/s41598-023-40277-4)

Stephen Findlay‑Wilson, Linda Easterbrook, Sandra Smith, Neville Pope, Matthew Aldridge, Gareth Humphries, Holger Schuhmann, Didier Ngabo, Emma Rayner, Ashley Otter, Thomas Coleman, Bethany Hicks, Rachel Halkerston, Kostis Apostolakis, Stephen Taylor, Susan Fotheringham, Amanda Horton, Irene CanoCejas, Matthew Wand, Julia A. TreeMark Sutton, Victoria Graham, Roger Hewson, Stuart Dowall*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

Correction to: Scientific Reports, published online 25 August 2023 The original version of this Article contained errors in Table 2, where the data in the columns ‘Purified antibody’ and ‘Affinity-purified antibody’ was interchanged for the Antigen ‘RBD’. The correct and incorrect data appears below. Incorrect: (Table presented.) Purified antibody Affinity-purified antibody RBD 1194 9295 1699 8669 2535 17,871 2952 15,735 Correct: (Table presented.) Purified antibody Affinity-purified antibody RBD 9295 1194 8669 1699 17,871 2535 15,735 2952 The original Article has been corrected.

Original languageEnglish
Article number15419
JournalScientific Reports
Volume13
Issue number1
DOIs
Publication statusPublished - Dec 2023

Bibliographical note

Publisher Copyright:
© 2023, Springer Nature Limited.

Fingerprint

Dive into the research topics of 'Publisher Correction: Refinement of an ovine-based immunoglobulin therapy against SARS-CoV-2, with comparison of whole IgG versus F(ab′)2 fragments (Scientific Reports, (2023), 13, 1, (13912), 10.1038/s41598-023-40277-4)'. Together they form a unique fingerprint.

Cite this